Jose M Galarza

Summary

Affiliation: New York Medical College
Country: USA

Publications

  1. ncbi request reprint Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge
    Jose M Galarza
    Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA
    Viral Immunol 18:244-51. 2005
  2. ncbi request reprint Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge
    Jose M Galarza
    Department of Microbiology and Immunology, New York Medical College, Valhalla, New York 10595, USA
    Viral Immunol 18:365-72. 2005
  3. ncbi request reprint A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1)
    Demetrius Matassov
    TechnoVax, Tarrytown, New York
    Viral Immunol 20:441-52. 2007

Collaborators

  • Demetrius Matassov
  • Albert Cupo

Detail Information

Publications3

  1. ncbi request reprint Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge
    Jose M Galarza
    Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA
    Viral Immunol 18:244-51. 2005
    ....
  2. ncbi request reprint Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge
    Jose M Galarza
    Department of Microbiology and Immunology, New York Medical College, Valhalla, New York 10595, USA
    Viral Immunol 18:365-72. 2005
    ....
  3. ncbi request reprint A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1)
    Demetrius Matassov
    TechnoVax, Tarrytown, New York
    Viral Immunol 20:441-52. 2007
    ..These results suggest that it is feasible to make a safe and immunogenic vaccine to protect against the extremely virulent 1918 virus, using a novel and safe cell-based technology...